Influence of glycosylation pattern on the molecular properties of monoclonal antibodies

References

• Walsh CT, Garneau-Tsodikova S, Gatto GJ Jr.. Protein posttranslational modifications: the chemistry of proteome diversifications. Angew Chem Int Ed Engl 2005; 44:7342 - 72; http://dx.doi.org/10.1002/anie.200501023; PMID: 16267872
   PubMed Web of Science ®Google Scholar
• Walsh G, Jefferis R. Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol 2006; 24:1241 - 52; http://dx.doi.org/10.1038/nbt1252; PMID: 17033665
   PubMed Web of Science ®Google Scholar
• Van Damme P, Hole K, Pimenta-Marques A, Helsens K, Vandekerckhove J, Martinho RG, Gevaert K, Arnesen T. NatF contributes to an evolutionary shift in protein N-terminal acetylation and is important for normal chromosome segregation. PLoS Genet 2011; 7:e1002169; http://dx.doi.org/10.1371/journal.pgen.1002169; PMID: 21750686
   PubMedGoogle Scholar
• Yokoyama A, Katsura S, Ito R, Hashiba W, Sekine H, Fujiki R, Kato S. Multiple post-translational modifications in hepatocyte nuclear factor 4α. Biochem Biophys Res Commun 2011; 410:749 - 53; http://dx.doi.org/10.1016/j.bbrc.2011.06.033; PMID: 21708125
   PubMed Web of Science ®Google Scholar
• Prigge ST, Kolhekar AS, Eipper BA, Mains RE, Amzel LM. Amidation of bioactive peptides: the structure of peptidylglycine alpha-hydroxylating monooxygenase. Science 1997; 278:1300 - 5; http://dx.doi.org/10.1126/science.278.5341.1300; PMID: 9360928
   PubMed Web of Science ®Google Scholar
• Prigge ST, Mains RE, Eipper BA, Amzel LM. New insights into copper monooxygenases and peptide amidation: structure, mechanism and function. Cell Mol Life Sci 2000; 57:1236 - 59; http://dx.doi.org/10.1007/PL00000763; PMID: 11028916
   PubMed Web of Science ®Google Scholar
• Brown MA, Stenberg LM. Biopharmaceuticals: post-translational modification carboxylation and hydroxylation. In: Walsh G, ed. Post-translational modification of protein biopharmaceuticals. Weinheim: Wiley-VCH Verlag GmbH & Co., 2009:209-52.
   Google Scholar
• Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 2007; 25:21 - 50; http://dx.doi.org/10.1146/annurev.immunol.25.022106.141702; PMID: 17029568
   PubMed Web of Science ®Google Scholar
• Cohen P. Signal integration at the level of protein kinases, protein phosphatases and their substrates. Trends Biochem Sci 1992; 17:408 - 13; http://dx.doi.org/10.1016/0968-0004(92)90010-7; PMID: 1333658
   PubMed Web of Science ®Google Scholar
• Mann M, Ong SE, Grønborg M, Steen H, Jensen ON, Pandey A. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol 2002; 20:261 - 8; http://dx.doi.org/10.1016/S0167-7799(02)01944-3; PMID: 12007495
   PubMed Web of Science ®Google Scholar
• Spiro RG. Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 2002; 12:43R - 56R; http://dx.doi.org/10.1093/glycob/12.4.43R; PMID: 12042244
   PubMed Web of Science ®Google Scholar
• Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993; 3:97 - 130; http://dx.doi.org/10.1093/glycob/3.2.97; PMID: 8490246
   PubMed Web of Science ®Google Scholar
• Dubé S, Fisher JW, Powell JS. Glycosylation at specific sites of erythropoietin is essential for biosynthesis, secretion, and biological function. J Biol Chem 1988; 263:17516 - 21; PMID: 3182860
   PubMed Web of Science ®Google Scholar
• Shields RL, Lai J, Keck R, O’Connell LY, Hong K, Meng YG, Weikert SH, Presta LG. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem 2002; 277:26733 - 40; http://dx.doi.org/10.1074/jbc.M202069200; PMID: 11986321
   PubMed Web of Science ®Google Scholar
• Kukuruzinska MA, Lennon K. Protein N-glycosylation: molecular genetics and functional significance. Crit Rev Oral Biol Med 1998; 9:415 - 48; http://dx.doi.org/10.1177/10454411980090040301; PMID: 9825220
   PubMedGoogle Scholar
• Krapp S, Mimura Y, Jefferis R, Huber R, Sondermann P. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol 2003; 325:979 - 89; http://dx.doi.org/10.1016/S0022-2836(02)01250-0; PMID: 12527303
   PubMed Web of Science ®Google Scholar
• Jefferis R. Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov 2009; 8:226 - 34; http://dx.doi.org/10.1038/nrd2804; PMID: 19247305
   PubMed Web of Science ®Google Scholar
• Kanda Y, Yamada T, Mori K, Okazaki A, Inoue M, Kitajima-Miyama K, Kuni-Kamochi R, Nakano R, Yano K, Kakita S, et al. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types. Glycobiology 2007; 17:104 - 18; http://dx.doi.org/10.1093/glycob/cwl057; PMID: 17012310
   PubMed Web of Science ®Google Scholar
• Zhou Q, Shankara S, Roy A, Qiu H, Estes S, McVie-Wylie A, Culm-Merdek K, Park A, Pan C, Edmunds T. Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function. Biotechnol Bioeng 2008; 99:652 - 65; http://dx.doi.org/10.1002/bit.21598; PMID: 17680659
   PubMed Web of Science ®Google Scholar
• Crispin M, Bowden TA, Coles CH, Harlos K, Aricescu AR, Harvey DJ, Stuart DI, Jones EY. Carbohydrate and domain architecture of an immature antibody glycoform exhibiting enhanced effector functions. J Mol Biol 2009; 387:1061 - 6; http://dx.doi.org/10.1016/j.jmb.2009.02.033; PMID: 19236877
   PubMed Web of Science ®Google Scholar
• Zheng K, Bantog C, Bayer R. The impact of glycosylation on monoclonal antibody conformation and stability. MAbs 2011; 3:568 - 76; http://dx.doi.org/10.4161/mabs.3.6.17922; PMID: 22123061
   PubMed Web of Science ®Google Scholar
• Fabian H, Naumann D. Methods to study protein folding by stopped-flow FT-IR. Methods 2004; 34:28 - 40; http://dx.doi.org/10.1016/j.ymeth.2004.03.004; PMID: 15283913
   PubMed Web of Science ®Google Scholar
• Surewicz WK, Mantsch HH. New insight into protein secondary structure from resolution-enhanced infrared spectra. Biochim Biophys Acta 1988; 952:115 - 30; http://dx.doi.org/10.1016/0167-4838(88)90107-0; PMID: 3276352
   PubMed Web of Science ®Google Scholar
• Mimura Y, Church S, Ghirlando R, Ashton PR, Dong S, Goodall M, Lund J, Jefferis R. The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Mol Immunol 2000; 37:697 - 706; http://dx.doi.org/10.1016/S0161-5890(00)00105-X; PMID: 11275255
   PubMed Web of Science ®Google Scholar
• Ionescu RM, Vlasak J, Price C, Kirchmeier M. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. J Pharm Sci 2008; 97:1414 - 26; http://dx.doi.org/10.1002/jps.21104; PMID: 17721938
   PubMed Web of Science ®Google Scholar
• Ryan MH, Petrone D, Nemeth JF, Barnathan E, Björck L, Jordan RE. Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid. Mol Immunol 2008; 45:1837 - 46; http://dx.doi.org/10.1016/j.molimm.2007.10.043; PMID: 18157932
   PubMed Web of Science ®Google Scholar
• Raju TS, Scallon B. Fc glycans terminated with N-acetylglucosamine residues increase antibody resistance to papain. Biotechnol Prog 2007; 23:964 - 71; http://dx.doi.org/10.1002/bp070118k; PMID: 17571902
   PubMed Web of Science ®Google Scholar
• Gaza-Bulseco G, Liu H. Fragmentation of a recombinant monoclonal antibody at various pH. Pharm Res 2008; 25:1881 - 90; http://dx.doi.org/10.1007/s11095-008-9606-3; PMID: 18473123
   PubMed Web of Science ®Google Scholar
• Feige MJ, Walter S, Buchner J. Folding mechanism of the CH2 antibody domain. J Mol Biol 2004; 344:107 - 18; http://dx.doi.org/10.1016/j.jmb.2004.09.033; PMID: 15504405
   PubMed Web of Science ®Google Scholar
• Raju TS, Scallon BJ. Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain. Biochem Biophys Res Commun 2006; 341:797 - 803; http://dx.doi.org/10.1016/j.bbrc.2006.01.030; PMID: 16442075
   PubMed Web of Science ®Google Scholar
• Rudd PM, Joao HC, Coghill E, Fiten P, Saunders MR, Opdenakker G, Dwek RA. Glycoforms modify the dynamic stability and functional activity of an enzyme. Biochemistry 1994; 33:17 - 22; http://dx.doi.org/10.1021/bi00167a003; PMID: 8286336
   PubMed Web of Science ®Google Scholar
• Ren D, Zhang J, Pritchett R, Liu H, Kyauk J, Luo J, Amanullah A. Detection and identification of a serine to arginine sequence variant in a therapeutic monoclonal antibody. J Chromatogr B Analyt Technol Biomed Life Sci 2011; 879:2877 - 84; http://dx.doi.org/10.1016/j.jchromb.2011.08.015; PMID: 21900054
   PubMed Web of Science ®Google Scholar